Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II results on the activity of BMS-247550 monotherapy in advanced colorectal cancer

Aug. 31, 2004

Roche seeks European approval of Tarceva for NSCLC

Aug. 30, 2004

IND filing for Provecta

Aug. 30, 2004

New caspase activators prepared and tested by Cytovia researchers

Aug. 30, 2004

Antiangiogenic agents targeting VEGFR kinase designed at Novartis

Aug. 30, 2004

Sterix presents new dual aromatase/steroid sulfatase inhibitor

Aug. 26, 2004

Roche seeks new indication for Xeloda in U.S., E.U.

Aug. 26, 2004

HGS-TR2J enters clinical development

Aug. 26, 2004

CuraGen collaborates with NCI on PXD-101 development

Aug. 26, 2004

Orphan drug designations for forodesine

Aug. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.